Luis Umaña, M.D., is a clinical geneticist at Children's Health℠ who specializes in inborn errors of metabolism (rare genetic conditions that affect how the body turns food into energy). His dedication to patients diagnosed with conditions such as phenylketonuria (PKU), maple syrup urine disease and Sanfilippo syndrome, is unwavering. Through newborn screenings, Dr. Umaña works to ensure these rare conditions are detected through comprehensive testing early in infancy.
Dr. Umaña earned his medical degree at Universidad Colegio Mayor de Nuestra Señora del Rosario. He completed his residency in pediatrics at St. Barnabas Hospital. Dr. Umaña also completed a second residency in clinical genetics and his fellowship in medical biochemical genetics at Baylor College of Medicine.
Dr. Umaña uses his knowledge of genetics to help patients receive a proper diagnosis and receive evidence-based care throughout every stage of their life. He actively participates in research involving the identification and proper treatment of inborn errors of metabolism. He also works as part of the Texas Department of Health's Newborn Screening Program in the Metabolic Consultants Work Group that helps children across the state get properly screened for inborn errors of metabolism.
He has been named to Texas Rising Stars in 2016, 2017 by Texas Monthly Magazine and D Magazine’s list of Best Doctors in 2018.
Dr. Umaña has also written chapters for textbooks used as reference by pediatricians and subspecialists reviewing different metabolic disorders.
He is board certified by the American Board of Pediatrics and the American Board of Medical Genetics and Genomics, and is fluent in both English and Spanish.
Education and Training
- Medical School
- Colegio Mayor/Nuestra Senora del Rosario (2003)
- Baylor College of Medicine - Houston GME (2012), Medical Genetics
St. Barnabas Hospital (2010), Pediatrics
- Baylor College of Medicine - Houston GME (2013), Medical Genetics
- Board Certification
- American Board of Medical Genetics and Genomics
Departments and Programs
- Clinical management of inborn errors of metabolism
- MCTP2 is a dosage-sensitive gene required for cardiac outflow tract development., Lalani SR, Ware SM, Wang X, Zapata G, Tian Q, Franco LM, Jiang Z, Bucasas K, Scott DA, Campeau PM, Hanchard N, Umaña L, Cast A, Patel A, Cheung SW, McBride KL, Bray M, Craig Chinault A, Boggs BA, Huang M, Baker MR, Hamilton S, Towbin J, Jefferies JL, Fernbach SD, Potocki L, Belmont JW Hum. Mol. Genet. 2013 Nov 22 21 4339-48
- A male newborn with VACTERL association and Fanconi anemia with a FANCB deletion detected by array comparative genomic hybridization (aCGH)., Umaña LA, Magoulas P, Bi W, Bacino CA Am. J. Med. Genet. A 2011 Dec 155A 12 3071-4
- Mediated learning experience and concept maps: a pedagogical tool for achieving meaningful learning in medical physiology students., González HL, Palencia AP, Umaña LA, Galindo L, Villafrade M LA Adv Physiol Educ 2008 Dec 32 4 312-6
- American Board of Medical Genetics
- American Board of Pediatrics
Awards and Honors
- Resident Teaching Award - Albert Einstein College of Medicine (2009)